Richard Kim, MD
Internal Medicine · Dayton, OHNPI 1285930875
Payments from drug & device makers
Across 519 payments — averaging $721.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$116K
- Lilly USA, LLC$73K
- Teva Pharmaceuticals USA, Inc.$33K
- Axsome Therapeutics, Inc.$32K
- Impel Pharmaceuticals Inc.$30K
- Pfizer$26K
- plus $64K from 15 others
Across 2 payments — averaging $2547.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$5K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 209 | $115,538 |
| Lilly USA, LLC | 113 | $72,718 |
| Teva Pharmaceuticals USA, Inc. | 36 | $33,229 |
| Axsome Therapeutics, Inc. | 22 | $32,282 |
| Impel Pharmaceuticals Inc. | 27 | $30,108 |
| Pfizer | 19 | $26,473 |
| Biohaven Pharmaceuticals, Inc. | 34 | $18,562 |
| Eli Lilly | 4 | $16,231 |
| Amgen | 16 | $14,843 |
| Biohaven Pharmaceutical Holding Company Ltd. | 11 | $8,673 |
| Impel Pharmaceuticals LLC | 6 | $4,851 |
| Noah Medical Corporation | 4 | $242 |
| Galderma Laboratories, L.p. | 1 | $186 |
| Upsher-smith Laboratories LLC | 5 | $109 |
| Lundbeck LLC | 3 | $51 |
| Biogen | 1 | $39 |
| Supernus Pharmaceuticals, Inc. | 2 | $35 |
| Collegium Pharmaceutical, Inc. | 2 | $28 |
| Novartis | 2 | $23 |
| SK Life Science, Inc. | 1 | $18 |
| Amneal Pharmaceuticals LLC | 1 | $16 |
How this compares
$374,254 in reported general payments places this provider in the 95th percentile of 4,428 internal medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other internal medicine in Dayton
- Ugochukwu NwokoroDayton$975K
- Isaac HumphreyDayton$224K
- Amita OzaDayton$195K
- Antoinette PragalosCincinnati$27.8M
- Steven FolkerthBeavercreek$9.1M
- Charles EgerCincinnati$8.7M
- Vadim KoshkinCleveland$6.1M
- Nizar DaboulMaumee$4.7M
- Douglas LoganCincinnati$4.7M
- Seref BornovaliLoveland$4.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.